Company profile · free preview

Stevanato Group S.p.A.

STVN · NYSE · Healthcare · Updated 11/18/2026

Five-year financials

Fiscal year
Revenue
Net income
Diluted EPS
Operating cash flow
Free cash flow
Cash
Total debt

Financials are being prepared.

Want the story behind these numbers? Ask Osiris anything about Stevanato Group S.p.A.'s filings — free.

Create free account

Stevanato Group S.p.A. return on capital (fiscal 2025)

ROIC

7.7%

Return on capital

7.6%

Return on equity

9.7%

Return on assets

5.7%

Gross margin

29.0%

Operating margin

16.8%

Net debt / EBITDA

1.13x

Stevanato Group S.p.A. insider buying and selling

Recent open-market trades reported on Form 4. Context only — not a reason to buy or sell.

DateInsiderTypeSharesPrice
2026-08-07Santel LucianoSale2,023$20.09
2026-08-07Dal Lago MarcoSale4,209$20.09
2026-08-07Magistretti ElisabettaSale2,045$20.09
2026-06-15Balachandran MadhavanSale1,493$17.09
2026-06-15Flynn KarenSale1,493$17.09
2026-06-15FEDERICI WILLIAM JSale1,493$17.09
2026-06-15MOREL DONALD E JRSale1,493$17.09

SEC filings

No filings stored yet.

Ask anything about Stevanato Group S.p.A.'s filings

"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.

Start researching free

Compare STVN head-to-head

More Healthcare companies